Physician Payment Reforms: A Step, Not a Solution

For decades, fee-for-service (FFS) has dominated physician compensation, a system where clinicians receive payment for each service rendered: every consultation, every procedure, every test. This model, while straightforward to administer, inherently encourages a higher volume of services, regardless of their necessity or impact on patient health. Critics argue FFS contributes to over-treatment, fragmented care, and unsustainable healthcare expenditure, particularly in systems striving for universal coverage and equitable access. The push for reform stems from a recognition that simply paying for more activity does not equate to better health for populations.¹

The current wave of reforms, often termed 'value-based care' initiatives, attempts to link physician reimbursement to quality metrics, patient satisfaction, and cost efficiency. These models include bundled payments, accountable care organizations (ACOs), and pay-for-performance (P4P) schemes. Bundled payments, for instance, provide a single payment for all services related to a specific episode of care, such as a hip replacement or a course of chemotherapy. This encourages coordination among providers and discourages unnecessary interventions within that episode. ACOs, on the other hand, hold groups of providers accountable for the total cost and quality of care for a defined patient population, sharing savings if quality targets are met and costs are kept below benchmarks.²

What the reforms actually measured

Early implementations of these alternative payment models (APMs) have yielded mixed results. In the United States, the Medicare Shared Savings Program (MSSP), a prominent ACO model, reported that in 2022, 53% of participating ACOs generated shared savings, totaling $1.8 billion. However, only 38% of ACOs actually received shared savings payments after accounting for quality performance and other factors. The average quality score for all MSSP ACOs in 2022 was 90.8%, indicating a general adherence to process and outcome measures. Still, the financial impact on overall healthcare spending has been incremental, not transformative.³

European initiatives, while structurally different due to varying national healthcare systems, share similar goals. In the UK, the Quality and Outcomes Framework (QOF) for general practitioners, a P4P scheme, has been in place since 2004. It rewards practices for achieving targets across various clinical areas, such as managing chronic diseases like diabetes and hypertension, and for organizational standards. Data from NHS Digital consistently show high achievement rates for QOF indicators, often exceeding 95% for many clinical targets. But, critics argue that while QOF improves care for measured conditions, it may divert attention from unmeasured areas and does not necessarily translate to a holistic improvement in patient health or a reduction in health inequalities. The focus on specific metrics can lead to 'teaching to the test,' where care is optimized for reported indicators rather than broader patient needs.⁴

The design of these reforms often involves complex risk adjustment mechanisms to account for patient severity and socioeconomic factors, aiming to prevent providers from avoiding sicker patients. But, accurately risk-adjusting for the myriad factors influencing patient outcomes remains a significant challenge. Many models also struggle with attribution, determining which provider is responsible for a patient's outcomes, especially in complex cases involving multiple specialists. The administrative burden associated with tracking quality metrics and managing complex payment calculations also presents a substantial hurdle for many practices, particularly smaller ones without extensive administrative support.⁵

Another limitation of current reforms is their often siloed approach. Many APMs target specific conditions or episodes of care, failing to address the broader systemic issues that drive healthcare costs, such as pharmaceutical pricing, administrative overhead, or social determinants of health. A payment model for diabetes management, for example, may improve HbA1c levels but cannot, by itself, address food insecurity or lack of access to exercise facilities, which are critical drivers of diabetic complications. The reforms also frequently overlook the impact on specialist care, where FFS remains deeply entrenched, particularly for procedural specialties.⁶

The trial was not powered to detect differences in long-term population health outcomes, and that gap matters. While individual quality metrics may show improvement, the ultimate goal of these reforms is to bend the cost curve and improve the health of entire populations, a goal that requires a much longer observation period and broader systemic changes than most current models encompass. The data collected often focuses on process measures rather than hard clinical endpoints or patient-reported outcomes, making it difficult to ascertain the true impact on patient well-being.⁷

Still, these reforms represent a necessary evolution. They force a conversation about value and accountability in healthcare, moving beyond the simplistic notion that more care is always better care. The challenge lies in refining these models to be more comprehensive, less administratively burdensome, and truly aligned with patient-centered outcomes, rather than just process metrics. Without addressing the underlying structural issues and ensuring adequate support for clinicians navigating these new systems, the full potential of value-based care will remain largely unrealized.⁸